Norgen Biotek Developing POC MDx Technologies with $821K Award

The company will focus its development efforts on non-invasive, urine-based, rapid detection systems for diagnosing sexually transmitted infections and other diseases, such as tuberculosis.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories